NIOSH supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty with respect to individuals, including enrolled WTC responders and certified-eligible WTC survivors, receiving monitoring or treatment under subtitle B, of the James
Zadroga 9/11 health and Compensation Act.
NIOSH seeks to achieve a suitable mix of projects that help advance treatment effectiveness and the understanding of health impacts related to the September 2001 terrorist attacks.This FOA invites applications from researchers who are at the early stage of their independent careers or those who have not had substantial prior NIH/CDC funding.
Importantly, applicants are expected to propose research approaches for which there are minimal or no preliminary data.